The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background Depression has been associated with delayed presentation, inadequate treatment, and poor survival in patients with cancer. Methods Using Surveillance, Epidemiology and End Results and Medicare linked data (1992–2005), we identified patients with pancreatic adenocarcinoma (N = 23,745). International Classification of Diseases, 9th edition, Clinical Modification codes were used to evaluate depression during the 3 to 27 months before the diagnosis of cancer. The effect of depression on receipt of therapy and survival was evaluated in univariate and multivariate models. Results Of patients with pancreatic cancer in our study, 7.9% had a diagnosis of depression (N = 1,868). Depression was associated with increased age, female sex, white race, single or widowed status, and advanced stage disease (P < .0001). In an adjusted model, patients with locoregional disease and depression had 37% lower odds of undergoing surgical resection (odds ratio, 0.63; 95% confidence interval, 0.52–0.76). In patients with locoregional disease, depression was associated with lower 2-year survival (hazard ratio, 1.20; 95% confidence interval, 1.09–1.32). After adjusting for surgical resection, this association was attenuated (hazard ratio, 1.14; 95% confidence interval, 1.04–1.26). In patients who underwent surgical resection, depression was a significant predictor of survival (hazard ratio, 1.34; 95% confidence interval, 1.04–1.73). Patients with distant disease and depression had 21% lower odds of receiving chemotherapy (odds ratio, 0.79; 95% confidence interval, 0.70–0.90). After adjusting for chemotherapy for distant disease, depression was no longer a significant predictor of survival (hazard ratio, 1.03; 95% confidence interval, 0.97–1.09). Conclusion The decreased survival associated with depression appears to be mediated by a lower likelihood of appropriate treatment in depressed patients. Accurate recognition and treatment of pancreatic cancer patients with depression may improve treatment rates and survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465
Prevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 2×
“a prevalence ranging from 33% to 71%.(18,20,22,24) Symptoms of depression, such as pain, fatigue, sleep and memory disturbances, anorexia, and weight loss may overlap with those of cancer, making the diagnosis of depression unclear or delayed.”
BackgroundDo stress-related psychosocial factors contribute to cancer incidence and survival?
Chida, Y., Hamer, M., Wardle, J., & Steptoe, A. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1134 · Cited by 1,072 · cited 1×
“receiving definitive treatment, and poorer survival in patients with a variety of cancer types.(16,19,25,26,28,32,33) In our population-based study, pre-existing depression was a significant predictor of survival in patients with adenocarcinoma of the pancreas.”
BackgroundNational Institutes of Health State of the Science Conference Statement
(2005) · Sleep · doi:10.1093/sleep/28.9.1049 · Cited by 745
Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/eufn-rv1k-y3tr-fk0l · Cited by 621
Psychological distress and cancer mortality
Hamer, M., Chida, Y., & Molloy, G. J. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.11.002 · Cited by 282
Anxiety and depression in cancer patients compared with the general population
HINZ, A., KRAUSS, O., HAUSS, J. P., HÖCKEL, M., KORTMANN, R. D., STOLZENBURG, J. U., & SCHWARZ, R. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2009.01088.x · Cited by 241
Psychological Distress and Cancer Survival: A Follow-Up 10 Years After Diagnosis
Brown, K. W., Levy, A. R., Rosberger, Z., & Edgar, L. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000077503.96903.a6 · Cited by 213
Cited by
Recent progress in pancreatic cancer
Wolfgang, C. L., Herman, J. M., Laheru, D. A., Klein, A. P., Erdek, M. A., Fishman, E. K., & Hruban, R. H. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21190 · Cited by 910
Canoui‐Poitrine, F., Reinald, N., Laurent, M., Guery, E., Caillet, P., David, J., Tournigand, C., Lagrange, J., Bastuji‐Garin, S., Lemogne, C., et al. (2016) · Psycho-Oncology · doi:10.1002/pon.3886 · Cited by 71
“On the other hand, depression has been associated with higher risk of delayed cancer diagnosis, thus leading to higher stage at time of diagnosis [10].”
BackgroundPsychological treatments to improve quality of life in cancer contexts: a meta-analysis
de la Torre-Luque, A., Gambara, H., López, E., & Cruzado, J. A. (2016) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2015.07.005 · Cited by 67
Støer, N. C., Bouche, G., Pantziarka, P., Sloan, E. K., Andreassen, B. K., & Botteri, E. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1953136 · Cited by 22
Metadata
- Authors
- Boyd, C. A., Benarroch-Gampel, J., Sheffield, K. M., Han, Y., Kuo, Y.-F., & Riall, T. S.
- Venue
- Surgery
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 152
- Issue
- 3
- Pages
- 403-413
- ISSN
- 0039-6060 (ISSN-L)
- OpenAlex
- W2044681170
- Cited by
- 83
- References
- 10
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.